Related references
Note: Only part of the references are listed.HIV-1 Entry Cofactor: Functional cDNA Cloing of a Seven-Transmembrane, G protein-Coupled Receptor
Yu Feng et al.
JOURNAL OF IMMUNOLOGY (2011)
Design and synthesis of 6-fluoro-2-naphthyl derivatives as novel CCR3 antagonists with reduced CYP2D6 inhibition
Ippei Sato et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Discovery of potent CCR4 antagonists: Synthesis and structure-activity relationship study of 2,4-diaminoquinazolines
Kazuhiro Yokoyama et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyllpiperidin-4-yl}benzamide derivatives as novel CCR3 antagonists
Ippei Sato et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Potent CCR4 antagonists: Synthesis, evaluation, and docking study of 2,4-diaminoquinazolines
Kazuhiro Yokoyama et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists
Robert J. Cherney et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists
Alexander Pasternak et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Potent antagonists of the CCR2b receptor.: Part 3:: SAR of the (R)-3-aminopyrrolidine series
Wilna J. Moree et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Identification of novel series of human CCR1 antagonists
Yun Feng Xie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists
Alexander Pasternak et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Substituted dipiperidine alcohols as potent CCR2 antagonists
Mingde Xia et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Maraviroc: The first of a new class of antiretroviral agents
Rodger D. MacArthur et al.
CLINICAL INFECTIOUS DISEASES (2008)
Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists
Robert J. Cherney et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts
Sonia Vallet et al.
BLOOD (2007)
Synthesis, structure - Activity relationship and in vivo antiinflammatory efficacy of substituted dipiperidines as CCR2 antagonists
Mingde Xia et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists
Mingde Xia et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation
Emma L. Wise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists
Cyrille F. Kuhn et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists
Cecile Pegurier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Potent and selective CC-chemokine receptor-2 (CCR2) antagonists as a potential treatment for asthma
Bharat Lagu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2
Gabor Butora et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-activity relationships of novel, highly potent, selective, and orally active CCRI antagonists
Yun Feng Xie et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
CC chemokine receptor-3 (CCR3) antagonists: Improving the selectivity of DPC168 by reducing central ring lipophilicity
James R. Pruitt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Small molecule antagonists of the CC chemokine receptor 4 (CCR4)
Douglas F. Burdi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Piperazinyl CCR1 antagonists - optimization of human liver microsome stability
Matthew F. Brown et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists
Lihu Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Core exploration in optimization of chemokine receptor CCR4 antagonists
Ashok V. Purandare et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Diaryl substituted pyrazoles as potent CCR2 receptor antagonists
Anthony B. Pinkerton et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders
T. Ellingsen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The attraction of chemokines as a target for specific anti-inflammatory therapy
JE Pease et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Blockade of chemokine signaling in patients with multiple sclerosis
F. Zipp et al.
NEUROLOGY (2006)
Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model
Eline Menu et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation
Patricia C. Fulkerson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
4-amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties
Gabor Butora et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Novel, orally bioavailable γ-aminoamide CC chemokine receptor 2 (CCR2) antagonists
Alexander Pasternak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists
LH Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Optimization of 2-aminothiazole derivatives as CCR4 antagonists
XM Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
A novel, selective, and orally available antagonist for CC chemokine receptor 3
T Morokata et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice
RP Gladue et al.
JOURNAL OF IMMUNOLOGY (2006)
Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
IF Charo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031
K Suzuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction
AD Fryer et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Optimization of CCR4 antagonists: Side-chain exploration
AV Purandare et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Chemokines in rheumatic diseases
Z Szekanecz et al.
CURRENT DRUG TARGETS (2006)
Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis
L Revesz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344
CM Brodmerkel et al.
JOURNAL OF IMMUNOLOGY (2005)
The clinical potential of chemokine receptor antagonists
S Ribeiro et al.
PHARMACOLOGY & THERAPEUTICS (2005)
The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: Antagonists versus agonists
PC Ting et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Identification of chemokine receptor CCR4 antagonist
AV Purandare et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency
GV De Lucca et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists
PC Ting et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist
FL de Mendonça et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
2-mercaptoimidazoles, a new class of potent CCR2 antagonists
G Van Lommen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists
JG Varnes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists
S Allen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts
DJ Min et al.
ARTHRITIS AND RHEUMATISM (2004)
N-benzylindole-2-carboxylic acids:: potent functional antagonists of the CCR2b chemokine receptor
JG Kettle et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Impact of engagement of FcδRI and CC chemokine receptor 1 on mast cell activation and motility
M Toda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives
WJ Moree et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge
C Pilette et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives
N Imai et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Novel CCR1 antagonists with improved metabolic stability
MF Brown et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template
JC Kath et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Potent small molecule CCR1 antagonists
JC Kath et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions
BS Bochner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases
RP Gladue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
CCR4 blockade does not inhibit allergic airways inflammation
DM Conroy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
CCR2: Characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach
TA Berkhout et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Identification and characterization of novel antagonists of the CCR3 receptor
U Warrior et al.
JOURNAL OF BIOMOLECULAR SCREENING (2003)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
CCR1 chemokine receptor antagonist
T Saeki et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
CCR1+/CCR5+mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis
C Trebst et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Conformationally restricted indolopiperidine derivatives as potent CCR2B receptor antagonists
J Witherington et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1
D Dhanak et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2
D Dhanak et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Discovery of a novel CCR3 selective antagonist
A Naya et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Design, synthesis, and discovery of a novel CCR1 antagonist
A Naya et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45RO+ T cells
C Weber et al.
BLOOD (2001)
A non-peptide functional antagonist of the CCR1 chemokine receptor is effective in rat heart transplant rejection
R Horuk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration
JR White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Chemokines and their receptors in allograft rejection
WW Hancock et al.
CURRENT OPINION IN IMMUNOLOGY (2000)
A small molecule antagonist of chemokine receptors CCR1 and CCR3 - Potent inhibition of eosinophil function and CCR3-mediated HIV-1 entry
I Sabroe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
CCR2B receptor antagonists: Conversion of a weak HTS hit to a potent lead compound
IT Forbes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists - Binding to a common chemokine receptor motif within the helical bundle
T Mirzadegan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1
M Liang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock
Y Chvatchko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo
CM Lloyd et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection
W Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
